한빛사논문
Min Hee Parka,b,c, Misun Leed,e, Geewoo Name, Mingeun Kimd, Juhye Kangd, Byung Jo Choia,f, Min Seock Jeonga,f, Kang Ho Parka,b,c, Wan Hui Hana,b,c, Eunyoung Takg,h, Min Sun Kimg,h, Juri Leed, Yuxi Lini, Young-Ho Leei,j,k, Im-Sook Songl, Min-Koo Choim, Joo-Yong Leeg,h, Hee Kyung Jina,f,1, Jae-sung Baea,b,c,1, and Mi Hee Limd,1
a Kyungpook National University Alzheimer’s Disease Research Institute, Kyungpook National University, 41566 Daegu, Republic of Korea; b Department of Physiology, Cell and Matrix Research Institute, School of Medicine, Kyungpook National University, 41944 Daegu, Republic of Korea; c Department of Biomedical Science, BK21 Plus Kyungpook National University Biomedical Convergence Program, Kyungpook National University, 41944 Daegu, Republic of Korea; d Department of Chemistry, Korea Advanced Institute of Science and Technology, 34141 Daejeon, Republic of Korea; e Department of Chemistry, Ulsan National Institute of Science and Technology, 44919 Ulsan, Republic of Korea; f Department of Laboratory Animal Medicine, College of Veterinary Medicine, Kyungpook National University, 41566 Daegu, Republic of Korea; g Asan Institute for Life Sciences, Asan Medical Center, 05505 Seoul, Republic of Korea; h Department of Convergence Medicine, University of Ulsan College of Medicine, 05505 Seoul, Republic of Korea; i Protein Structure Group, Korea Basic Science Institute, Ochang, 28199 Cheongju, Chungbuk, Republic of Korea; j Neurovascular Research Group, Korea Brain Research Institute, 41068 Daegu, Republic of Korea; k Bio-Analytical Science, University of Science and Technology, 34113 Daejeon, Republic of Korea; l College of Pharmacy and Research Institute of Pharmaceutical Sciences, Kyungpook National University, 41566 Daegu, Republic of Korea; and m College of Pharmacy, Dankook University, 31116 Cheon-an, Republic of Korea
1To whom correspondence may be addressed.
Abstract
As a central feature of neuroinflammation, microglial dysfunction has been increasingly considered a causative factor of neurodegeneration implicating an intertwined pathology with amyloidogenic proteins. Herein, we report the smallest synthetic molecule (N,N′-diacetyl-p-phenylenediamine [DAPPD]), simply composed of a benzene ring with 2 acetamide groups at the para position, known to date as a chemical reagent that is able to promote the phagocytic aptitude of microglia and subsequently ameliorate cognitive defects. Based on our mechanistic investigations in vitro and in vivo, 1) the capability of DAPPD to restore microglial phagocytosis is responsible for diminishing the accumulation of amyloid-β (Aβ) species and significantly improving cognitive function in the brains of 2 types of Alzheimer’s disease (AD) transgenic mice, and 2) the rectification of microglial function by DAPPD is a result of its ability to suppress the expression of NLRP3 inflammasome-associated proteins through its impact on the NF-κB pathway. Overall, our in vitro and in vivo investigations on efficacies and molecular-level mechanisms demonstrate the ability of DAPPD to regulate microglial function, suppress neuroinflammation, foster cerebral Aβ clearance, and attenuate cognitive deficits in AD transgenic mouse models. Discovery of such antineuroinflammatory compounds signifies the potential in discovering effective therapeutic molecules against AD-associated neurodegeneration.
small molecule, antineuroinflammation, microglial phagocytosis, amyloid-β clearance, cognitive function
논문정보
관련 링크
연구자 키워드
연구자 ID
관련분야 연구자보기
관련분야 논문보기